F. Walton Dumas

Life Sciences, Digital Health and Medical Device Transactions

• Represented Gilead Sciences, Inc. in numerous transactions, including:
  • its $1.74 billion exclusive option to acquire Pionyr Immunotherapeutics Inc. (“Pionyr”), a clinical stage immune-oncology therapeutics company, consisting of the acquisition by Gilead of a 49.9% equity interest in Pionyr for $275 million, an option for Gilead to acquire the remaining equity interests of Pionyr for $315 million, and up to $1.15 billion of potential future milestone payments to Pionyr equityholders.
  • its $1.55 billion exclusive option to acquire Tizona Therapeutics, Inc. (“Tizona”), a clinical stage immuno-therapeutics company focused on the treatment of cancer and autoimmune diseases, consisting of the acquisition by Gilead of a 49.9% equity interest in Tizona for $300 million, and an option for Gilead to acquire the remaining equity interests of Tizona for up to $1.25 billion of additional consideration and future milestone payments to Tizona equityholders.
• Represented TPG in the $2 billion cash sale of Immucor, a leading provider of transfusion and transplantation diagnostic products, to Werfen, a global specialized diagnostics provider. 
• Represented Asklepios Biopharmaceutical Inc. (“AskBio”), an industry leading AAV-based gene therapy platform, in its $4 billion cash sale to Bayer, including $2 billion in up-front payments to former AskBio equityholders and an additional $2 billion of contingent future milestone payments. 
• Represented Ensemble Health Partners, a tech driven revenue cycle management company that helps healthcare providers optimize their revenue cycles, in its sale of a majority equity stake to a consortium of private equity sponsors.
• Represented Patient Square Capital, a dedicated healthcare investment firm, in its going private transaction with Eargo, Inc. a formerly Nasdaq listed (symbol: EAR) medical device company committed to improving hearing health.

Technology Transactions

• Represented Silver Lake Partners in its initial and subsequent investments in Waymo, an autonomous car technology company, previously wholly owned by Alphabet, Google’s parent company.
• Represented GI Partners in its $450 million acquisition of formerly Nasdaq listed GTY Technology Holdings Inc. (symbol: GTYH), a leading cloud-based technology solutions provider for the public sector. 
• Represented Qorvo, Inc., a leading radio frequency semiconductor company, in its acquisition of Decawave Limited, a pioneer in ultra-wideband technology and provider of UWB solutions for mobile, automotive and IoT applications, in a transaction named “Deal of the Year” by The Irish Times, representing one of the largest exits by an Irish technology company at the time. 
• Represented Silver Lake Partners in its Series C investment in Vacasa, an international vacation rental management company, and subsequent provision of emergency pandemic financing to Vacasa. 
• Represented Advanced Circuits Inc., a leading quick-turn PCB manufacturer, in $200 million cash sale to APCT, Inc., another leading PCB manufacturer. 
• Represented Daxko, a software company providing revenue cycle management and other services to non-profits, including YMCAs, Jewish Community Centers, Boys and Girls Clubs and other recreation centers, in its recapitalization and significant investment from Genstar.

Additional Representations

• Represented Alera Group, Inc., an independent national insurance and financial services company, in its multi-billion dollar stock for stock merger with Propel Insurance Agency, a leader of innovative insurance solutions.
• Represented GI Partners in its $1.05 billion all-cash acquisition of formerly Nasdaq listed Atlas Technical Consultants (symbol: ATCX), a leading provider of infrastructure and environmental solutions.